Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

3rd Pharma Meets AI Conference 2027

3rd Pharma Meets AI Conference on 19 and 20 April 2027 in Barcelona, hosted by UBIQ Events. Director-level executives from leading pharmaceutical companies share their expertise and real-world case studies on how artificial intelligence is...

SmartLab Exchange Europe 2027

The invitation-only forum for senior laboratory, digital transformation, data and R&D leaders exploring AI, laboratory automation and connected laboratory ecosystems. Operationalising AI & Digital Transformation to Accelerate Product...

VietPharma&Tech 2026

Vietnam Medical Devices Association highly appreciates Vietnam Advertisement and Fair Exhibition Joint Stock Company (VIETFAIR) organizing The international exhibition on Pharmaceutical Manufacturing Technology - VietPharmaTech 2026 / The...

SHARx’s Paul Pruitt Warns That Patent Expiration Does Not Guarantee Immediate Savings

A drug nearing patent expiration may seem like relief from high prices, but lower-cost competition can still take years to reach the market. Employers cannot control when a patent expires, a lawsuit is resolved, or when a biosimilar reaches the...

Estrella Immunopharma Highlights ARTEMIS® T-Cell Therapy Data at ASH 2026, Demonstrating Promising Leukemia Treatment Results

Estrella Immunopharma, Inc. a clinical-stage biopharmaceutical company developing next-generation ARTEMIS T-cell therapies for cancer and autoimmune diseases, highlighted preclinical findings from an abstract accepted for poster presentation at...

Bruker Announces the Appointment of Institute Director, Biopharma Entrepreneur, and Immunology Leader Dr. Eicke Latz to Its Board of Directors

Bruker Corporation announced that its Board of Directors is adding Eicke Latz, MD PhD to serve on its board of directors, effective as of January 1, 2027. Dr. Latz is an internationally recognized medical institute director, physician-scientist,...

CS Analytical to Offer Testing Services for Sunscreen Ingredients Used in Pharmaceutical and Cosmetic Products

CS Analytical (CSA), doing business as Raw Material Analytical (RMA), a cGMP laboratory dedicated to advancing product quality and patient safety, today announced that it is set to offer analytical testing for sunscreen ingredients used in...

ProBio Signs Exclusive Global Licensing Agreement with AbTis for Next-Generation ADC Development

ProBio, a global contract research, development, and manufacturing organization announced that it has entered into an exclusive global licensing agreement with AbTis Co., Ltd., a South Korean biotechnology company and subsidiary of Dong-A ST,...

Bayer’s SUNHARBO® (asundexian) Receives FDA Approval for Stroke Risk Reduction

Bayer announced that the U.S. Food and Drug Administration (FDA) has approved SUNHARBO® (asundexian), 50 mg tablets, a first-in-class, once daily, Factor XIa inhibitor indicated in combination with antiplatelet therapy to reduce the risk of stroke...

Tenpoint Therapeutics Announces the Launch of the YUVEZZI™ Telehealth Prescribing Program

Tenpoint Therapeutics, Ltd., a global commercial ophthalmic pharmaceutical company focused on developing groundbreaking treatments to improve vision in the aging eye, announced its telehealth prescribing program. This program connects eligible...

BE BOLD: BIMZELX® (bimekizumab-bkzx) demonstrates superior joint response rates versus SKYRIZI® (risankizumab-rzaa) at Week 16, with sustained clinical improvements through Week 24

UCB, a global biopharmaceutical company, announced Week 24 data for BIMZELX® (bimekizumab-bkzx) from BE BOLD, building on the study's previously reported Week 16 results, which demonstrated statistically significant superiority in ACR50 joint...

Avanzanite Announces an Exclusive Agreement to License and Market Zemcelpro® in Europe

Avanzanite Bioscience B.V. a European pharmaceutical company focused on rare diseases, announced the conclusion of an exclusive licensing agreement with Montreal-based company Cordex Biologics, an ExCellThera Group company (“ExCellThera”), a...

Lilly and Hims & Hers expand access to Lilly's FDA-approved medicines

Eli Lilly and Company announced an agreement to help expand access to Zepbound (tirzepatide) and Foundayo (orforglipron). Through the agreement, eligible patients who receive a prescription from a licensed provider on the Hims & Hers platform will...

Roche Receives FDA 510(k) Clearance for New cobas® eplex Respiratory Pathogen Panel 3, Enabling Customized Respiratory Testing to Meet Local Patient Needs

Roche announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the cobas® eplex respiratory pathogen panel 3 (RP3). Designed for the automated cobas® eplex system, this flexible syndromic test offers up to five customizable panel...

Sciensus Appoints James Tugendhat OBE as Its Chief Executive Officer

Sciensus has appointed James Tugendhat OBE as Chief Executive Officer, bringing more than 20 years of leadership experience across healthcare and complex service organisations. James was most recently Group CEO of HC-One, the UK's largest care...

KODAK PHARMACEUTICALS Expands Its Portfolio and Launches an Online Store in the U.S

Eastman Kodak Company announced the expansion of its KODAK PHARMACEUTICALS portfolio with the addition of KODAK® Normal Saline, 0.9%. The company also introduced a new U.S.-based online store designed to simplify purchasing for pharmaceutical,...

CELSET Launches Korean Botulinum Toxin Type A Brand SOLTOX in International Markets

CELSET INC., a Korean biotechnology company specializing in medical aesthetics, has launched SOLTOX, its botulinum toxin type A brand, introducing a Korean botulinum toxin brand to the international medical aesthetics industry. SOLTOX is presented...

Stevanato Group and Aptar Pharma Collaborate to Accelerate Pre-Filled Syringe System Selection

Stevanato Group S.p.A. a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced a collaboration with Aptar Pharma to provide...

MEPSGEN Launched NanoCalibur® Mini for Nanoparticle Formulation in Small Volumes

MEPSGEN US, Inc., a global innovator in drug delivery system platforms, announced the launch of NanoCalibur® Mini, an automated system for small-volume nanoparticle formulation designed for early-stage drug discovery and development. Nanoparticles...

Aptar Pharma Expands Next-Generation Pulmonary Drug Delivery Capabilities with Acquisition of Pulmotree

Aptar Pharma, a global leader in drug delivery, dosing, protection technologies and services, announced the strategic acquisition of PULMOTREE, a Munich, Germany-based life science company specializing in pulmonary drug delivery systems for...